Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,288 public trials 1,201 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Completed

A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumors

NCT02983045

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +55 more
Locations
  • UCSD, Moores Cancer Center La Jolla, California, United States
  • UCLA Los Angeles, California, United States
  • Stanford Cancer Institute Stanford, California, United States
  • University of Colorado, Denver Denver, Colorado, United States
View all 58 locations
View Trial Details
Completed

Re-introduction of Pemetrexed and Cisplatin With Prolonged Angiogenic Blocking by Bevacizumab in Advanced Lung Cancer.

NCT01705184

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Avignon - Institut Sainte-Catherine Avignon, France
  • Caen - Centre François Baclesse Caen, France
  • Caen - CHU Côte de Nacre Caen, France
  • Centre Hospitalier Chauny, France
View Trial Details
Completed

Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer

NCT02219711

Conditions
Adenocarcinoma, Advanced Cancer, Bronchial Neoplasms, +28 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • University of California, San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Sarcoma Oncology Research Center Santa Monica, California, United States
View all 43 locations
View Trial Details
Completed

Analysis of Soluble Mediators,Cytokines and FACs as Prognostic Factors in Advanced Non-squamous Lung Carcinoma

NCT03156868

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Hospital de Elche Elche, Alicante, Spain
  • Hospital de Torrevieja Torrevieja, Alicante, Spain
  • ICO-Badalona Badalona, Barcelona, Spain
  • Hospital General de Catalunya Sant Cugat del Vallès, Barcelona, Spain
View all 25 locations
View Trial Details
Completed

An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026)

NCT02041533

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Southern Cancer Center, Inc. Mobile, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Local Institution - 0034 Tucson, Arizona, United States
  • Local Institution - 0016 Stanford, California, United States
View all 141 locations
View Trial Details

Related conditions